• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing

ARK Innovation: Feast or Famine?

Here's what aggressive traders can do.
By BRUCE KAMICH
Feb 23, 2022 | 02:30 PM EST
Stocks quotes in this article: ARKK, TSLA, TDOC

In his "No Huddle Offense" segment of Tuesday's Mad Money program, Jim Cramer sounded off against chasing innovation at all costs, a strategy made popular by Cathie Wood and her ARK Innovation ETF (ARKK) .

You can't just innovate for the sake of innovation, you need to also make money, Cramer said. If your company doesn't have a path to profitability, then it's simply not worth owning.

Let's look at some charts.

In this daily Japanese candlestick chart of ARKK, below, we can see that prices have been cut in half in less than four months. Prices are retesting the late January low on lighter volume than what was seen in the latter half of January. A light volume retest or even a slight new low on light volume is a short-term positive. The two most recent candles are a doji and a spinning top - both are a sign of balance between bulls and bears.

The On-Balance-Volume (OBV) line has been in a decline the past four months as traders have voted with their feet. In the bottom panel is the 12-day price momentum study which shows higher lows from early December to January and now in late February. Higher momentum lows tell you that the pace of the decline is slowing. When momentum is compared to the price action we have a bullish divergence - price is declining but the indicator is improving. A bullish divergence can foreshadow an upside reversal.

In this weekly bar chart of ARKK, below, we can see that prices have made a bigger decline since early 2021. Trading volume was very heavy into the January low. In the bottom panel is the slow stochastic indicator - one of many oversold/overbought indicators. The price action is very oversold or extended on the downside. Being oversold is not a good enough reason for me to be a buyer of ARKK.

In this daily Point and Figure chart of ARKK, below, we can see a potential downside price target in the $48 area.

The top holding in the ARKK ETF is Tesla (TSLA)  , so let's check the chart.

In this daily Japanese candlestick chart of TSLA, below, we can see that prices have made a significant decline this calendar year. Prices have just slipped below the 200-day moving average line and made a slight new low for the move down.

The OBV line is still pointed down but the 12-day momentum study shows us a higher low from late January until now - a small but promising bullish divergence when compared to prices.

Teladoc Health (TDOC) is the second largest holding in the ARKK ETF and its chart is interesting. In this daily candlestick chart of TDOC, below, we can see some positive clues - small real bodies, heavy trading volume and a larger bullish divergence than on the chart of TSLA (above).

Bottom line strategy: Aggressive traders who know how to get out in addition to getting in could go long ARKK at current levels risking a close below $60. Prices could rebound back to the $69 area in the short-term. This is just a short-term trade.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of TheStreet are restricted from trading individual securities.

TAGS: ETFs | Investing | Stocks | Technical Analysis | Trading | Asset Manager | Life Sciences | Technology | Technology Hardware & Equipment | Mad Money | Electric Vehicles

More from Investing

The Mask Gets Yanked Off of Goldilocks Narrative

James "Rev Shark" DePorre
Sep 21, 2023 4:29 PM EDT

The bulls' story always sounded like a stretch, and now they will have to develop a new narrative to help drive a recovery.

Holders of Discover Financial Are Discovering the Stock Is Heading Lower

Bruce Kamich
Sep 21, 2023 1:02 PM EDT

Let me show you what I am seeing and the key price levels to watch.

After Splunk Grab, Cisco's a Slam Dunk

Stephen Guilfoyle
Sep 21, 2023 11:54 AM EDT

I didn't like the idea of a cash deal at the start, but after going through the fundamentals, I think it's a wise move -- and here's why I'm adding the stock.

The Day After the Fed Meeting, I'm Gambling on This Stock

James "Rev Shark" DePorre
Sep 21, 2023 11:27 AM EDT

Here's why I like this gaming-related play, and why stocks could eventually offer some good entry points -- but not yet.

Darden Posts an Earnings Beat, But You May Want to Get Up From the Table

Bruce Kamich
Sep 21, 2023 10:46 AM EDT

Markets are a discounting mechanism.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 10:24 AM EDT BRUCE KAMICH

    This Could Get Messy

    A number of key stocks are getting close to import...
  • 01:41 PM EDT CHRIS VERSACE

    Latest AAP Podcast With Helene Meisler!

    Listen in as the Action Alerts PLUS podcast talks ...
  • 09:07 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    The Most Common and Costly Mistake in Investing
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login